Experience with the use of an investigational F(ab')2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt

Clinical Infectious Diseases

Volumn 23, Issue 2, 1996, Pages 337-340

  Hibbs, Richard G ^b   Todd Weber, J ^b   Corwin, Andrew ^b   Allos, Ban Mishu ^b   El Rehim, Mohammed Sohhi Abd ^b   El Sharkawy, Said ^b   Sarn, James E ^b   McKee Jr , Kelly T ^a  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; BOTULINUM TOXIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT;

ARTHRALGIA; ARTICLE; BOTULISM; CLINICAL PROTOCOL; CLOSTRIDIUM BOTULINUM; DRUG SAFETY; EDEMA; FOOD CONTAMINATION; HUMAN; HYPOTENSION; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; PRURITUS; RASH; SERUM SICKNESS; SHIVERING; URTICARIA;

EID: 16944366179     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.2.337     Document Type: Article

References (12)

1. Morris JG. Current trends in therapy of botulism in the United States. In: Lewis GE, ed. Biomedical aspects of botulism. New York: Academic Press, 1981:317-26.
2. Tacket CO, Shandera WX, Mann JM, Hrgrett NT, Blake PA. Equine antitoxin use and other factors that predict outcome in type A foodbome botulism. Am J Med 1984;76:794-8.
3. Whittaker RL, Gilbertson RB, Garrett AS. Botulism, type E: report of 8 simultaneous cases. Ann Intern Med 1964;6:448-54.
4. Dolman CE, Iida H. Type E botulism: its epidemiology, prevention and specific treatment. Can J Public Health 1963;54:293-308.
5. Koenig MG, Spickard A, Cardello MA, Rogers DE. Clinical and laboratory observations on type E botulism in man. Medicine (Baltimore) 1963; 43:517-45.
6. Black RE, Gunn RA. Hypersensitivity reactions associated with botulinal antitoxin. Am J Med 1980;69:567-70.
7. Fries L, Sjogren M, McKee K, Hamilton R, Thumar B, Peters CJ. Clearance kinetics and immunologic responses to "despeciated" equine botulinum antitoxin in human volunteers [abstract no 92]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991:114.
8. Weber JT, Hibbs RG Jr, Darwish A, et al. A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J Infect Dis 1993;167:451-4.
9. De Swarte RD. Drug allergy. In: Patterson R, ed. Allergic diseases diagnosis and management. 2nd ed. Philadelphia: JB Lippincott, 1980:452.
10. Naguwa SM, Nelson BL. Human serum sickness. Clin Rev Allergy 1985; 3:117-26.
11. Erffmeyer JE. Serum sickness. Ann Allergy 1986;56:105-9.
12. Investigator's brochure. Bofulinum F(ab′)2 antitoxin, heptavalent (equine derived). Document no. BB IND #3703. Ft. Detrick, Maryland: Office of the Surgeon General, Department of the Army, USAMRMC (MCMR-RCQ-HR).